Skip to main content

Migraine

  • Chapter
  • First Online:
Orofacial Disorders
  • 1251 Accesses

Abstract

  • Migraine is typically underdiagnosed and undertreated.

  • There is no cure for migraine; nevertheless there are numerous interventions that may help restore an improve life for sufferers. These measures should consider the patient in as broad an aspect as possible.

  • Triggering factors, neurogenic inflammation, vascular changes, and pain transmission should all be addressed aggressively.

  • Individualizing treatment and use of multiple modalities is essential.

Author was deceased at the time of publication.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Vos T, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163–96.

    Google Scholar 

  2. Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41(7):646–57.

    Article  PubMed  Google Scholar 

  3. Lipton RB, Scher AI, Kolodner K, et al. Migraine in the United States: epidemiology and patterns of health care use. Neurology. 2002;58(6):885–94.

    Article  PubMed  Google Scholar 

  4. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. Cephalalgia. 1988;8(Suppl 7):1–96.

    Google Scholar 

  5. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. Cephalalgia. 2004;24(Suppl 1):160. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013:33:629–808.

    Google Scholar 

  6. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–1602.

    Google Scholar 

  7. Waters WE. Headache (series in clinical epidemiology). London: Croom Helm; 1986.

    Google Scholar 

  8. Selby G, Lance JW. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry. 1960;47:23–32.

    Article  Google Scholar 

  9. Silberstein SD, Lipton RB, Goadsby PJ. Headache in clinical practice. Oxford: ISIS Medical Media; 1998.

    Google Scholar 

  10. Woods RP, Iacoboni M, Maziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med. 1994;331:1689–92.

    Article  PubMed  Google Scholar 

  11. Moskowitz MA, Henrikson BM, Markowitz S, Saito K. Intra- and extravascular nociceptive mechanisms and the pathogenesis of head pain. In: Olsen J, Edvinsson L, editors. Basic mechanisms of headache. Amsterdam: Elsevier; 1988. p. 429.

    Google Scholar 

  12. Moskowitz MA, Cutrer FM. Sumatriptan: a receptor-targeted treatment for migraine. Annu Rev Med. 1993;44:145–54.

    Article  PubMed  Google Scholar 

  13. Peroutka SJ. The pharmacology of current antimigraine drugs. Headache. 1990;30(Suppl 1):5–11.

    Article  PubMed  Google Scholar 

  14. Weiller C, May A, Limmeroth, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995;1:658–60.

    Article  PubMed  Google Scholar 

  15. Strassman AM, Raymond SA, Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature. 1996;384:560–3.

    Article  PubMed  Google Scholar 

  16. Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain. 2000;89:107–10.

    Article  Google Scholar 

  17. Burstein R, Yarnitsky D, Goor-Aryeh I, et al. An association between migraine and cutaneous allodynia. Ann Neurol. 2000;47:614–24.

    Article  PubMed  Google Scholar 

  18. Burstein R, Jukubowski M, Burstein R. Analgesic Triptan action in animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol. 2004;55:27–36.

    Article  PubMed  Google Scholar 

  19. Lipton RB, Dodick D, Sadosvsky R, Kolodner K, Endicott J, Hettiarachchi J, Harrison W. A self-administered screener for migraine in primary care: the ID MigraineTM validation study. Neurology. 2003;61:375–82.

    Article  PubMed  Google Scholar 

  20. Silberstein SD. Preventive treatment of migraine: an overview. Cephalalgia. 1997;17(2):67–72.

    Article  PubMed  Google Scholar 

  21. Silberstein SD, Saper JR, Freitag FG. Migraine diagnosis and treatment. In: Silberstein SD, Lipton RB, Dalessio DE, editors. Wolff’s headache and other head pain. 7th ed. Oxford: Oxford University Press; 2001. p. 121–237.

    Google Scholar 

  22. Silberstein SD, Goadsby PJ. Migraine: preventive treatment. Cephalalgia. 2002;22(7):491–512.

    Article  PubMed  Google Scholar 

  23. Diener HC, Kaube H, Limmroth V. A practical guide to the management and prevention of migraine. Drugs. 1998;56(5):811–24.

    Article  PubMed  Google Scholar 

  24. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000a;55(6):754–62.

    Article  PubMed  Google Scholar 

  25. Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener H-C, Brin MF. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache J Head Face Pain. 2010;50(6):921–36.

    Article  Google Scholar 

  26. Gray RN, Goslin RE, McCrory DC, et al. Drug treatments for the prevention of migraine headache. technical review 2.3. Duke University: US Dept of Health and Human Services, Agency for Health Care Policy and Research; February 1999. NTIS Accession No. PB99–127953. Available at: http://www.clinpol.mc.duke.edu/.

  27. Ramadan NM, Silberstein SD, Freitag FG, Gilbert TT, Frishberg BM. Evidence-based guidelines for migraine headache in prevention of migraine. Neurology [serial online]. Available at: http://www.neurology.org. Accessed 25 Apr 2000.

  28. Snow V, Weiss K, Wall E, et al. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med. 2002;137:840–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven B. Graff-Radford DDS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Graff-Radford, S.B. (2017). Migraine. In: Ferreira, J., Fricton, J., Rhodus, N. (eds) Orofacial Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-51508-3_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-51508-3_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-51507-6

  • Online ISBN: 978-3-319-51508-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics